Munetaka Takekuma

18PUBLICATIONS
84CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 26, 2026
Guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer: 2025 edition by the Japan Society of Gynecologic Oncology.

|Sep 19, 2025
Atezolizumab, bevacizumab, and platinum chemotherapy in cervical cancer: results of Japanese population from BEATcc.

Munetaka Takekuma, Shin Nishio, Satoshi Yamaguchi

|Aug 27, 2025
Clinical outcomes and prognostic factors of adjuvant radiotherapy for vulvar cancer: a Japanese Gynecologic Oncology Group nationwide survey study.

Keisuke Tsuchida, Ken Ando, Noriyuki Okonogi

|May 21, 2025
Japan Society of Gynecologic Oncology 2023 guidelines for treatment of uterine body neoplasm.

Tohru Morisada, Yoichi Kobayashi, Satoru Nagase

|Apr 04, 2025
Quality indicators for endometrial cancer care in Japan.

Tamaki Kakuwa, Yuichi Ichinose, Ryoko Rikitake

|Sep 09, 2024
Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study.

Daisuke Aoki, Tsutomu Tabata, Satoshi Yanagida

Pageof 3

Frequent Collaborators

6 joint publications

Aikou Okamoto

5 joint publications

Shin Nishio

5 joint publications

Tsutomu Tabata

4 joint publications

Kazuhiro Takehara